Discontinuation report CEFTRIAXONE SODIUM FOR INJECTION
Report ID | 133886 |
Drug Identification Number | 02287633 |
Brand name | CEFTRIAXONE SODIUM FOR INJECTION |
Common or Proper name | CEFTRIAXONE SODIUM INJ 1GM |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | CEFTRIAXONE |
Strength(s) | 1G |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS |
Packaging size | 10 |
ATC code | J01DD |
ATC description | OTHER BETA-LACTAM ANTIBACTERIALS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2021-02-05 |
Remaining supply date | 2021-02-05 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | Item is disc |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2021-02-12 | French | Compare |
v1 | 2021-02-12 | English | Compare |
Showing 1 to 2 of 2